Healthcare & Life Sciences

RUBYnanomed

activeseries-c-plus
series-c-plus
Stage
2016
Founded
3
Investors

About

RUBYnanomed develops nanomedical therapies focused on innovative drug delivery systems and targeted treatments using nanotechnology.

Explore RUBYnanomed's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.